NRN1 and Alzheimer disease: Antibody characterization was conducted using Western blots and densitometry to assess the relative protein abundances of NRN1 in rodents, humans, and cell models.<h4>Results</h4>NRN1 has a TREAT-AD target risk score of 3.29 out of 5.